Biomarker and pharmacodynamic activity of the transforming growth factor‐beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors. - Robbrecht, Debbie; Grob, Jean‐Jacques; Bechter, Oliver; Simonelli, Matteo; Doger, Bernard; Borbath, Ivan; Butler, Marcus O.; Cheng, Tina; Romano, Patricia Martin; Pons‐Tostivint, Elvire; Di Nicola, Massimo; Curigliano, Giuseppe; et al. (CTS: Clinical & Translational Science, 2024)